This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Authoring team

  • a high lifetime risk of thrombosis is conferred by the presence of antiphospholipid antibodies in the blood

  • of 'young' people who suffer strokes, up to 20% of them have antiphospholipid syndrome

  • up to 20% of cases of recurrent miscarriage have antiphospholipid syndrome

  • up to 20% of cases of DVT have antiphospholipid syndrome

  • there is a possibility that the antibodies directed against phospholipids, such as those found in antiphospholipid syndrome, may have a causative role in the development of atheroma

In addition to the antiphospholipid antibodiy (aPL) profile of patients, other considerations that influence thrombotic risk include the presence of other thrombotic risk factors (eg, inherited thrombophilia, pregnancy, immobilization, surgery) and the presence of systemic lupus erythematosus (SLE)

  • patients with SLE have an increased risk of thrombosis compared with the general population, and those who also have isolated but persistently positive aPL appear to be at further risk

Reference:

  • Hughes G. Why 'sticky blood' syndrome has implications beyond thrombosis. Pulse (28/7/01), 29-31.
  • Tektonidou MG, Laskari K, Panagiotakos DB, and Moutsopoulos HM. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 2009;61(1):29-36.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.